Table 1 Demographic and clinical characteristics of study groups defined by BMI

Age (years)

56.2 ± 12.2

66.7 ± 8.4*

61.4 ± 8.7

BMI (kg/m2)

24.8 ± 2.3

25.5 ± 2.4

34.2 ± 3.7*

Hypertension

10%

64.5%*

63.3%*

Smoker

8.3%

22.6%*

15.2%

Aspirin use

5.6%

53%*

39%*

Insulin use

0.0%

29%*

36.7%*

Metformin use

0.0%

80.6%*

69.6%*

ACEI/ARB use

16.0%

64.5%*

63.3%*

CC Blocker use

14.6%

38.7%*

32.9%

Beta blocker use

16.76%

48.4%*

46.8%*

Statin use

13.2%

69.4%*

58.2%*

Fasting plasma glucose(mg/dl)

93.4 ± 9.8

147.9 ± 43.9*

164.4 ± 58.4*

HbA1C (%)

5.9 ± 0.4

7.4 ± 1.4*

8.1 ± 1.7*

Low density lipoprotein cholesterol (mg/dl)

119.0 ± 31.6

99.0 ± 30.3

93.8 ± 29.3*

High density lipoprotein cholesterol (mg/dl)

53.7 ± 12.0

46.3 ± 10.4*

45.1 ± 13.1*

Triglycerides (mg/dl)

119.0 ± 59.1

144.3 ± 104.8

166.0 ± 109.3*

C-reactive protein (mg/dl)

0.3 ± 0.3

0.5 ± 0.8*

0.9 ± 1.3*

HOMA IR

1.9 ± 1.2

6.0 ± 13.0

10.9 ± 17.7*

Creatinine (mg/dl)

0.9 ± 1.2

1.1 ± 0.9*

1.0 ± 0.5*

Systolic blood pressure (mmHg)

124.7 ± 15.6

141.4 ± 19.9*

154.1 ± 20.1*

Diastolic blood pressure (mmHg)

69.3 ± 9.0

74.1 ± 9.6*

78.7 ± 9.9*

AI(%)

29.6 ± 9.6

36.8 ± 8.8*

35.6 ± 11.3*

PWV (m/sec)

6.1 ± 1.0

7.5 ± 2.7*

7.5 ± 3.2*